Association of Different Tidal Volumes and Postoperative Pulmonary Complications

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age51+
SponsorFirst Affiliated Hospital of Zhejiang University

About this trial

The incidence of lung cancer in China is increasing year by year. Currently, the treatment primarily based on video-assisted thoracoscopic surgery (VATS) is still considered the optimal approach for early-stage non-small cell lung cancer. The widespread application of traditional one-lung ventilation (OLV) technology not only achieves effective lung isolation, but also facilitates exposure of the surgical field during thoracoscopic surgery, making it more convenient for surgeons to operate. However, the occurrence of hypoxemia during one-lung ventilation may pose a risk to patient safety.

One-lung ventilation can lead to increased intrapulmonary shunt, ventilation/perfusion (V/Q) mismatch, and ischemic-hypoxic lung injury. Hypoxemia is the major problem during one-lung ventilation. Postoperative pulmonary complications (PPCs) are among the major complications following thoracic and general anesthesia surgeries, including atelectasis, pneumonia, and respiratory failure, which significantly prolong hospital stay and increase mortality.

Low tidal volume lung-protective ventilation strategies have been widely implemented. Additionally, permissive hypercapnia, reducing peak airway pressure to minimize barotrauma, and decreasing FiO₂ all help reduce pulmonary complications.Recently, researchers have focused on optimizing ventilation strategies during OLV, such as using PEEP or low VT ventilation alone or in combination, or exploring different combinations of tidal volume and respiratory frequency under consistent minute ventilation (VE), aiming to balance lung protection and oxygenation, reduce complications, and improve patient outcomes.

However, to date, there is still no gold standard tidal volume ventilation strategy for reducing pulmonary complications in patients undergoing lung resection.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age > 50 years.

ASA physical status I-II.

The cardiopulmonary and other vital organ functions are basically normal, and the patient is able to tolerate surgery.

Ariscat score > 26.

Disqualifiers

Patients who refuse to participate in the clinical trial, or have cognitive impairment or impaired ability to understand and express themselves.

ASA physical status ≥ III.

Patients with congestive heart failure, severe aortic stenosis, or extensive pleural adhesions.

Patients with severe psychiatric disorders or allergy to anesthesia-related medications.

Trial population

Patients undergoing video-assisted lung surgery

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Postoperative Pulmonary Complications (PPCs)

Postoperative Pulmonary Complications (PPCs): Incidence of any PPC within 7 days postoperatively

Time frame
1-7 days after surgery

Secondary outcomes

1

Incidence of hypoxemia

Incidence of hypoxemia: Occurring before the end of surgery

Time frame
during surgery
2

Length of Hospital Stay

Length of Hospital Stay

Time frame
through study completion, an average of 1 year

Other outcomes

1

Intraoperative Oxygenation Index

Intraoperative Oxygenation Index

Time frame
during surgery
2

Intraoperative Lung Compliance

Intraoperative Lung Compliance

Time frame
during surgery
3

Intraoperative Driving Pressure

Intraoperative Driving Pressure

Time frame
during surgery
4

Intraoperative Dead Space to Tidal Volume Ratio (Vd/Vt)

Intraoperative Dead Space to Tidal Volume Ratio (Vd/Vt)

Time frame
during surgery

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: